A) Corrosiveness B) Biocompatibility C) Toxicity D) Inflammability
A) To provide a structure for cells to grow and organize B) To induce inflammation C) To prevent regeneration D) To block cell growth
A) Thermal conductivity B) Fatigue resistance C) Biodegradability D) Chemical stability
A) Biocompatibility B) High cost C) Heavy weight D) Corrosion
A) Enhanced surface interactions and properties B) Reduce mechanical strength C) Decrease biocompatibility D) Increase toxicity
A) Polyethylene B) PMMA C) Silicone rubber D) Hydroxyapatite
A) Fibroblasts B) Keratinocytes C) Macrophages D) Red blood cells
A) To increase toxicity B) To promote inflammation C) To accelerate degradation D) To prevent infections
A) Quantum mechanics B) Biomaterials science or biomaterials engineering C) Astrophysics D) Marine biology
A) There is no difference between them B) Biological materials are always synthetic C) Biomaterials are engineered, while biological materials are naturally produced D) Biomaterials cannot be used in medical applications
A) Pure water-based solutions B) Only natural fibers C) Metallic components, polymers, ceramics, or composite materials D) Exclusively organic compounds
A) Exclusively through animal testing B) Using only historical data without new testing C) By computational routines predicting molecular effects based on limited in vitro experimentation D) Through random trial and error methods
A) The spontaneous aggregation of particles without external forces. B) A process requiring mechanical manipulation to form structures. C) An assembly method that uses magnetic fields. D) The random distribution of particles in a solution.
A) The chemical composition of particles. B) The external forces applied to the system. C) The spatial scale of the unit cell (lattice parameter). D) The temperature at which assembly occurs.
A) External guidance and control. B) Chemical bonding between particles. C) Self-organization. D) Random particle distribution.
A) 60 nm. B) 1.5 nm. C) 3 nm. D) 70 to 100 nm.
A) 80/20. B) 50/50. C) 70/30. D) About 60/40.
A) At the gaps between collagen fibrils. B) Randomly throughout the matrix. C) Within the mineral phase only. D) On the surface of tropocollagen molecules.
A) "Bricks" with dimensions of 0.5. B) 1 μm diameter rods. C) 20 to 30 nm layers. D) 60 nm diameter canals.
A) Calcium carbonate. B) Chitin. C) Hydroxyapatite. D) Collagen.
A) An amorphous structure. B) A random distribution. C) A cubic pattern. D) A helical pattern.
A) 20 to 30 nm. B) 60 nm. C) 1 μm. D) 70 to 100 nm.
A) ISO 10993 B) ISO 9001 C) ISO 27001 D) ISO 14001
A) Amino acids B) Fatty acids C) Nucleotides D) Sugars
A) Artificial skin scaffold B) Dental filling material C) Heart valve coating D) Bone graft substitute
A) Stainless steel B) Pyrolytic carbon C) Polyethylene terephthalate D) Calcium sulfate
A) Plant fibers B) Metal wires C) Synthetic polymers D) Animal skin
A) 5 different configurations B) 20 different configurations C) 10 different configurations D) 14 different configurations
A) Nylon B) Kevlar C) Dacron D) Spandex
A) Inflammatory reaction B) Foreign body response (FBR) C) Immune response D) Healing process
A) Microstructure level B) Molecular level C) Sub atomic level D) Ultra-structure level
A) 60% B) 75% C) 25% D) 49%
A) Non-biodegradable B) Electrically conductive C) Chemically reactive D) Mechanically strong
A) 3 nm. B) 20 to 30 nm. C) 1 μm. D) 60 nm.
A) 1.5 nm. B) 3 mm. C) 70 to 100 nm. D) Approximately 60 nm.
A) Biomimetics B) Biocompatibility C) Biodegradation D) Biofabrication
A) Early 1950s B) 1980s C) 2000s D) Later 1960s
A) Wound closure B) Tissue growth stimulation C) Drug delivery D) Bone strengthening
A) Acute phase B) Chronic phase C) Resolution phase D) Healing phase
A) Non-degradable B) Biocompatible C) Brittle D) Toxic
A) Alignment B) Size C) Shape D) Elasticity
A) Silica B) Polyetheretherketone (PEEK) C) Polymers D) Liposomes
A) Starch B) Cellulose C) DNA D) Proteins
A) Eosinophils B) Macrophages C) Lymphocytes D) Neutrophils
A) Foreign body response B) Graft-versus-host disease C) Acute inflammation only D) Biocompatibility
A) Joint replacements B) Skin repair devices C) Contact lenses D) Dental implants
A) Immune cells B) The implant C) No structures are isolated D) Only the damaged tissue
A) Cellulose B) Silk C) DNA D) Starch
A) Inert B) Non-biodegradable C) Toxic D) Biodegradable
A) Young's Modulus B) Tensile strength C) Flexural rigidity D) Ductility
A) Cyclic olefin polymer (COP) B) Polypropylene (PP) C) Polycarbonate (PC) D) Polyetherimide (PEI)
A) Suppress the immune response entirely B) Direct the immune response rather than circumvent it C) Avoid any interaction with the immune system D) Elicit a strong immune reaction
A) Toughness B) Elasticity C) Flexural rigidity D) Compressive strength
A) Ceramic B) Stainless steel C) Ivory D) Aluminum
A) Mass Spectrometry B) Scanning Electron Microscopy C) X-ray Diffraction D) Nuclear Magnetic Resonance
A) Macrostructure B) Edge dislocation C) Point defects D) Line defects |